SCHEMBL4601226

SCHEMBL4601226

O=[N+]([O-])c1c(Br)nn(CCO)c1NCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.46
CYP3A4 P08684 1/20 0.43
HTT P42858 5/20 0.43
MAPT P10636 3/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 4/20 0.42
ALDH1A1 P00352 4/20 0.42
LMNA P02545 4/20 0.40
MAPK1 P28482 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA13 Q8N1Q1 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
USP2 O75604 1/20 0.39
RECQL P46063 1/20 0.39
F2 P00734 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2932348 0.93 HTT (0.46) POLBCYP3A4HTTMAPTKDM4E
SCHEMBL6755855 0.90 HTT (0.47) POLBCYP3A4HTTMAPTKDM4E
SCHEMBL27603447 0.88 MAPT (0.45) POLBCYP3A4HTTMAPTKDM4E
SCHEMBL1026866 0.88 KDM4E (0.45) POLBCYP3A4HTTMAPTKDM4E
SCHEMBL8919318 0.88 HTT (0.44) POLBCYP3A4HTTMAPTKDM4E
SCHEMBL8920097 0.86 CYP3A4 (0.44) POLBCYP3A4HTTMAPTKDM4E
SCHEMBL5386521 0.85 POLB (0.40) POLBCYP3A4HTTMAPTKDM4E
SCHEMBL5416063 0.85 KDM4E (0.43) POLBCYP3A4HTTMAPTKDM4E
SCHEMBL6755732 0.84 MAPT (0.42) POLBCYP3A4HTTMAPTKDM4E
SCHEMBL5399448 0.84 CYP3A4 (0.43) POLBCYP3A4HTTMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101287710-A Preparation of 4, 5-diamino-1- (substituted) pyrazoles and their acid addition salts EASTMAN CHEM CO (US) 2008-10-15 CN disclosed
EP-1912950-A2 PREPARATION OF 4,5-DIAMINO-1-(SUBSTITUTED)-PYRAZOLE AND ACID ADDITION SALTS THEREOF EASTMAN CHEMICAL COMPANY (US) 2008-04-23 EP disclosed
WO-2007021873-A2 PREPARATION OF 4,5-DIAMINO-1-(SUBSTITUTED)-PYRAZOLE AND ACID ADDITION SALTS THEREOF EASTMAN CHEMICAL COMPANY (US) 2007-02-22 WO disclosed
US-20070037987-A1 Preparation of 4,5-diamino-1-(substituted)-pyrazole and acid addition salts thereof EASTMAN CHEMICAL COMPANY 2007-02-15 US disclosed
EP-1342716-A2 Preparation of 4,5-diamino-1-(2'-hydroxyethyl)-pyradazole and acid addition salts thereof EASTMAN CHEMICAL COMPANY (US) 2003-09-10 EP disclosed
US-6452019-B1 SIMPLIFIED PROCESS THAT DOES NOT INVOLVE TOXIC SOLVENTS NOR MULTIPLE ISOLATIONS OF INTERMEDIATE PRODUCTS; CYCLIZATION OF ALKYL(ETHOXYMETHYLENE)CYANOACETATE AND 2-HYDROXY-ETHYL-HYDRAZINE; DECARBOXYLATING; NITROSATION TO AMINATE EASTMAN CHEMICAL COMPANY 2002-09-17 US disclosed
US-5663366-A Process for the synthesis of 4,5-diaminopyrazole derivatives useful for dyeing hair WELLA AKTIENGESELLSCHAT (DE) 1997-09-02 US disclosed
EP-0618902-A1 PROCESS FOR PRODUCING 4,5-DIAMINO PYRAZOLE DERIVATIVES, THEIR USE FOR COLOURING HAIR AND NOVEL PYRAZOLE DERIVATIVES Wella Aktiengesellschaft (DE) 1994-10-12 EP disclosed
WO-1994008969-A1 PROCESS FOR PRODUCING 4,5-DIAMINO PYRAZOLE DERIVATIVES, THEIR USE FOR COLOURING HAIR AND NOVEL PYRAZOLE DERIVATIVES WELLA AKTIENGESELLSCHAFT (DE) 1994-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070037987-A1 Preparation of 4,5-diamino-1-(substituted)-pyrazole and acid addition salts thereof DDC, DAO, IL4I1 POLB 2020/4885CYP3A4 19/4885HTT 2849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.